Primary Navigation for the CDC Website
CDC en EspaƱol
Vaccine Safety
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
 Vaccine Safety Basics
bullet Information for Parents
bullet Why It's Important to Monitor Vaccine Safety
bullet How Vaccines Are Tested and Monitored
bullet Common Questions
bullet Vaccine Safety Concerns
bullet History of Vaccine Safety

 Public Health Activities
bullet Vaccine Adverse Event Reporting System (VAERS)
bullet Vaccine Safety Datalink (VSD) Project
bullet Priority Studies
bullet Rapid Cycle Analysis (RCA)
bullet Data-Sharing Program
bullet Publications
bullet MMRV Safety Monitoring of Febrile Seizures
bullet Clinical Immunization Safety Assessment (CISA) Network
bullet Brighton Collaboration
bullet Vaccine Technology
bullet Emergency Preparedness
bullet Publications
bullet Scientific Agenda

Rapid Cycle Analysis (RCA)

Recent events in the United States highlight the importance of setting up computerized reporting systems to detect adverse events as they happen. In 2005, the Vaccine Safety Datalink (VSD) Project team launched an active surveillance system called Rapid Cycle Analysis (RCA). Its goal is to monitor adverse events following vaccination (possible side effects) in near real time, so the public can be informed quickly of possible risks. The VSD Project team uses RCA to monitor newly licensed vaccines and new vaccine recommendations.

RCA data come from participating managed care organizations that include more than 8.8 million people annually, representing nearly 3% of the United States population. The RCA data contain no personal identifiers.

How RCA Works

RCA uses data that are updated every week. Potential adverse events that are monitored for each RCA project are based on—

Each week, the rate of adverse events that occurs in people who have received a particular vaccine are compared to the rate of adverse events that occurs in a similar group of people who have not received that vaccine. If the rate of adverse events among vaccinated people is significantly higher than among the comparison group, the vaccine may be associated with an adverse event. To find out if a vaccine truly increases the risk of a particular adverse event, VSD Project scientists conduct a formal epidemiologic study.

The VSD Project team is using RCA to monitor the safety of all newly licensed vaccines, including conjugated meningococcal vaccine, rotavirus vaccine, MMRV vaccine, Tdap vaccine, and HPV vaccine. In addition, plans are underway to use RCA to monitor the safety of seasonal influenza (flu) vaccinations.

Page last reviewed: September 24, 2008
Page last updated: June 9, 2008
Content source: Immunization Safety Office

  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention
1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
Public Inquiries: 1-800-CDC-INFO (232-4636); 1-888-232-6348 (TTY)
USA.govDHHS Department of Health
and Human Services